Author:
Friedlaender Alex,Naidoo Jarushka,Banna Giuseppe Luigi,Metro Giulio,Forde Patrick,Addeo Alfredo
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference84 articles.
1. Prognostic assessment after surgical resection for non-small cell lung cancer: Experiences in 2083 patients;Pfannschmidt;Lung Cancer,2007
2. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008
3. Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial;Kelly;J Clin Oncol,2015
4. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study;Zhong;Lancet Oncol,2018
5. Tada, H. et al. Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non–Small-Cell Lung Cancer With EGFR Mutation (IMPACT). J Clin Oncol 0, JCO.21.01729.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献